These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26180511)

  • 21. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis.
    Dahl JS; Christensen NL; Videbæk L; Poulsen MK; Carter-Storch R; Hey TM; Pellikka PA; Steffensen FH; Møller JE
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):142-8. PubMed ID: 24173271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment.
    Briand M; Dumesnil JG; Kadem L; Tongue AG; Rieu R; Garcia D; Pibarot P
    J Am Coll Cardiol; 2005 Jul; 46(2):291-8. PubMed ID: 16022957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.
    Khot UN; Novaro GM; Popović ZB; Mills RM; Thomas JD; Tuzcu EM; Hammer D; Nissen SE; Francis GS
    N Engl J Med; 2003 May; 348(18):1756-63. PubMed ID: 12724481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal timing of valve replacement in asymptomatic severe aortic stenosis.
    Bilen E; Ipek G; Ayhan H; Nacar AB; Kasapkara HA; Sani C; Basbug S; Kurt M; Bozkurt E
    J Heart Valve Dis; 2014 Sep; 23(5):524-33. PubMed ID: 25799699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis.
    Milano AD; Faggian G; Dodonov M; Golia G; Tomezzoli A; Bortolotti U; Mazzucco A
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):830-7. PubMed ID: 22244555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in left intraventricular pressure gradients after aortic valve replacement in aortic stenosis patients.
    Guerra M; Mendes-Ferreira P; Adão R; Pereira E; Vieira M; Lourenço AP; Brás-Silva C; Bastos P; Vouga L; Leite-Moreira AF
    Exp Physiol; 2017 Apr; 102(4):411-421. PubMed ID: 28194824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation.
    O'Sullivan CJ; Stortecky S; Heg D; Pilgrim T; Hosek N; Buellesfeld L; Khattab AA; Nietlispach F; Moschovitis A; Zanchin T; Meier B; Windecker S; Wenaweser P
    Eur Heart J; 2013 Nov; 34(44):3437-50. PubMed ID: 24096324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of left atrial booster-pump function with heart failure symptoms in patients with severe aortic stenosis and preserved left ventricular ejection fraction.
    Imanishi J; Tanaka H; Sawa T; Motoji Y; Miyoshi T; Mochizuki Y; Fukuda Y; Tatsumi K; Matsumoto K; Okita Y; Hirata K
    Echocardiography; 2015 May; 32(5):758-67. PubMed ID: 25230926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome.
    Vaquette B; Corbineau H; Laurent M; Lelong B; Langanay T; de Place C; Froger-Bompas C; Leclercq C; Daubert C; Leguerrier A
    Heart; 2005 Oct; 91(10):1324-9. PubMed ID: 16162627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure.
    Bergler-Klein J; Klaar U; Heger M; Rosenhek R; Gabriel H; Binder T; Pacher R; Maurer G; Baumgartner H
    Int J Cardiol; 2006 Nov; 113(2):174-80. PubMed ID: 16343663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of systolic ventricular muscle function in man: the end systolic index.
    Spann JF; Carabello BA; Gash AK; Denenberg BS; Donner RM; Maurer AH; Malmud LS; Siegel JA
    Herz; 1984 Oct; 9(5):255-69. PubMed ID: 6238885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study.
    Clavel MA; Messika-Zeitoun D; Pibarot P; Aggarwal SR; Malouf J; Araoz PA; Michelena HI; Cueff C; Larose E; Capoulade R; Vahanian A; Enriquez-Sarano M
    J Am Coll Cardiol; 2013 Dec; 62(24):2329-38. PubMed ID: 24076528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aortic valve replacement in true severe aortic stenosis with low gradient and low ejection fraction.
    Ozsöyler I; Lafci B; Emrecan B; Kestelli M; Bozok S; Ozbek C; Yesil M; Gürbüz A
    Heart Surg Forum; 2006; 9(4):E681-5. PubMed ID: 16757422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortic valve replacement in isolated severe aortic stenosis with left ventricular dysfunction: long-term survival and ventricular recovery.
    Rabus MB; Kirali K; Kayalar N; Tuncer EY; Toker ME; Yakut C
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):41-6. PubMed ID: 19196573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congestive heart failure in patients with valvular aortic stenosis. A clinical and echocardiographic Doppler study.
    Faggiano P; Rusconi C; Sabatini T; Ghizzoni G; Sorgato A; Gardini A
    Cardiology; 1995; 86(2):120-9. PubMed ID: 7728801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valve replacement for aortic stenosis with severe congestive heart failure and pulmonary hypertension.
    Snopek G; Pogorzelska H; Zielinski T; Rajecka A; Korewicki J; Biederman A; Kotlinski Z
    J Heart Valve Dis; 1996 May; 5(3):268-72. PubMed ID: 8793674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of valvuloarterial impedance and left ventricular longitudinal function in asymptomatic severe aortic stenosis involving three-cuspid valves.
    Zito C; Salvia J; Cusmà-Piccione M; Antonini-Canterin F; Lentini S; Oreto G; Di Bella G; Montericcio V; Carerj S
    Am J Cardiol; 2011 Nov; 108(10):1463-9. PubMed ID: 21872194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
    Jander N; Minners J; Holme I; Gerdts E; Boman K; Brudi P; Chambers JB; Egstrup K; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Rossebø A; Pedersen TR; Skjærpe T; Willenheimer R; Wachtell K; Neumann FJ; Gohlke-Bärwolf C
    Circulation; 2011 Mar; 123(8):887-95. PubMed ID: 21321152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
    O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.